Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 3
2005 4
2006 1
2007 1
2009 1
2011 2
2012 1
2013 3
2015 4
2016 5
2018 3
2019 5
2020 4
2021 4
2022 5
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Results by year

Filters applied: . Clear all
Page 1
Children's Oncology Group Trial AALL1231: A Phase III Clinical Trial Testing Bortezomib in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia and Lymphoma.
Teachey DT, Devidas M, Wood BL, Chen Z, Hayashi RJ, Hermiston ML, Annett RD, Archer JH, Asselin BL, August KJ, Cho SY, Dunsmore KP, Fisher BT, Freedman JL, Galardy PJ, Harker-Murray P, Horton TM, Jaju AI, Lam A, Messinger YH, Miles RR, Okada M, Patel SI, Schafer ES, Schechter T, Singh N, Steele AC, Sulis ML, Vargas SL, Winter SS, Wood C, Zweidler-McKay P, Bollard CM, Loh ML, Hunger SP, Raetz EA. Teachey DT, et al. Among authors: galardy pj. J Clin Oncol. 2022 Jul 1;40(19):2106-2118. doi: 10.1200/JCO.21.02678. Epub 2022 Mar 10. J Clin Oncol. 2022. PMID: 35271306 Free PMC article. Clinical Trial.
Lymphoma diagnostics: getting more from less.
Galardy PJ, Bedekovics T, Macintyre E, Miles RR. Galardy PJ, et al. Br J Haematol. 2019 Jun;185(6):1136-1141. doi: 10.1111/bjh.15788. Epub 2019 Feb 19. Br J Haematol. 2019. PMID: 30784044 Free article. Review.
Walking the tightrope: UCH-L1 as an mTOR inhibitor and B-cell oncogene.
Bedekovics T, Hussain S, Galardy PJ. Bedekovics T, et al. Among authors: galardy pj. Oncotarget. 2019 Aug 27;10(50):5124-5125. doi: 10.18632/oncotarget.27154. eCollection 2019 Aug 27. Oncotarget. 2019. PMID: 31497243 Free PMC article. No abstract available.
Symptomatic hyperammonemia secondary to recombinant Erwinia asparaginase.
Martin CE, Kohorst MA, Ferdjallah A, Kalmes JL, Johnson HM, Galardy PJ, Khan SP, Kuhn AK. Martin CE, et al. Among authors: galardy pj. Pediatr Blood Cancer. 2023 May;70(5):e30208. doi: 10.1002/pbc.30208. Epub 2023 Jan 12. Pediatr Blood Cancer. 2023. PMID: 36633209 No abstract available.
MRD at the End of Induction and EFS in T-cell Lymphoblastic Lymphoma: Children's Oncology Group Trial AALL1231.
Hayashi RJ, Hermiston ML, Wood BL, Teachey DT, Devidas M, Chen Z, Annett RD, Asselin BL, August K, Cho S, Dunsmore KP, Freedman JL, Galardy PJ, Harker-Murray P, Horton TM, Jaju A, Lam A, Messinger YH, Miles RR, Okada M, Patel S, Schafer ES, Schechter T, Shimano KA, Singh N, Steele A, Sulis ML, Vargas S, Winter SS, Wood C, Zweider-McKay PA, Loh ML, Hunger SP, Raetz EA, Bollard CM, Allen CE. Hayashi RJ, et al. Among authors: galardy pj. Blood. 2024 Mar 8:blood.2023021184. doi: 10.1182/blood.2023021184. Online ahead of print. Blood. 2024. PMID: 38457359
Discoveries: an innovative platform for publishing cutting-edge research discoveries in medicine, biology and chemistry.
Bucur O, Almasan A, Nikolajczyk BS, Nicolson GL, Lawler J, Velculescu VE, Draghici S, Leabu M, Avram D, Bucur I, Calautti E, Calin GA, Chauhan SC, Ciubotaru M, Constantinescu SN, Datta D, Duda DG, Friedman MT, Galardy PJ, Harris BT, Huarte M, Khalil AM, Marchetti D, Movileanu L, Nat R, Nucera C, Popa-Wagner A, Stancu AL, Zhu S, Liehn EA. Bucur O, et al. Among authors: galardy pj. Discoveries (Craiova). 2013 Dec 31;1(1):e1. doi: 10.15190/d.2013.1. Discoveries (Craiova). 2013. PMID: 32309535 Free PMC article.
44 results